| 摘要 |
The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include low concentrations of local anesthetics, a NSAID, an anticonvulsant, and/or other active ingredients. The transdermal cream may include lidocaine, prilocaine, meloxicam, and lamotrigine and/or topiramate. Alternatively, the transdermal cream may include a lidocaine/prilocaine base cream to which is added a fine powder of one or more ground up medications to form a compounded medication. The compounded medication in powder form may be generated from grinding up tablets of NSAIDs, anticonvulsants, nerve depressants, antidepressants, muscle relaxants, NMDA receptor antagonists, opiate or opioid agonists, and/or other agents. The compounded medication in powder form may include meloxicam, lamotrigine, topiramate, other active ingredients, and DMSO or Sterile Water for Irrigation. In another aspect, the present embodiments relate to methods of compounding medications and transdermal creams or gels. |
| 主权项 |
1. A method of compounding medication with a transdermal cream for the topical administration of a compounded therapy, the method comprising:
grinding up one or more commercial tablets selected from a NSAID (Non-Steroidal Anti-Inflammatory Drug), an anticonvulsant, a nerve depressant, a muscle relaxant, a NMDA (N-Methyl-D-aspartate) receptor antagonist, an opiate or opioid agonist, and an antidepressant into a fine powder of medication; and adding the fine powder of medication to a transdermal cream containing lidocaine in an amount between approximately 0.5% and approximately 5.0% by weight of the transdermal cream and prilocaine in an amount between approximately 0.5% and 5.0% by weight of the transdermal cream. |
